Cooper Companies
About: CooperCompanies is one of the largest eyecare companies in the us. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business with a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and Clariti, Cooper controls roughly one fourth of the us contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the us, and controls 17% of the us IUD market.
Employees: 15,000
Fund manager confidence
Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)
83% more first-time investments, than exits
New positions opened: 88 | Existing positions closed: 48
50% more funds holding in top 10
Funds holding in top 10: 4 [Q2] → 6 (+2) [Q3]
22% more capital invested
Capital invested by funds: $17.5B [Q2] → $21.4B (+$3.93B) [Q3]
5% more funds holding
Funds holding: 617 [Q2] → 646 (+29) [Q3]
8% less repeat investments, than reductions
Existing positions increased: 228 | Existing positions reduced: 248
2.9% less ownership
Funds ownership: 100.55% [Q2] → 97.65% (-2.9%) [Q3]
11% less call options, than puts
Call options by funds: $41.9M | Put options by funds: $47.2M
Research analyst outlook
3 Wall Street Analysts provided 1 year price targets over the past 3 months
3 analyst ratings
Citigroup Joanne Wuensch 60% 1-year accuracy 28 / 47 met price target | 23%upside $115 | Buy Maintained | 6 Dec 2024 |
Morgan Stanley Patrick Wood 55% 1-year accuracy 6 / 11 met price target | 9%upside $102 | Equal-Weight Maintained | 6 Dec 2024 |
Wells Fargo Larry Biegelsen 63% 1-year accuracy 29 / 46 met price target | 27%upside $118 | Overweight Maintained | 6 Dec 2024 |
Financial journalist opinion
